没有一个适合所有人的方法与apomorphine启动
Christopher Kobylecki1, Richard J B Ellis2
1Department of Neurology, Manchester Centre for Clinical Neurosciences, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, Salford, UK; Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Parkinsonism & related disorders
|June 1, 2025
概括
治疗帕金森病 (PD) 运动波动的持续皮下阿波莫芬输液 (CSAI) 可以在家开始. 家庭启动是安全的,有效的,与住院治疗相比,可以节省成本.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 持续的皮下阿波莫芬输液 (CSAI) 是晚期帕金森病 (PD) 运动波动的关键治疗方法.
- 获得CSAI的机会可能受到治疗启动的看法和实用性的限制.
- 住院治疗是常见的,但可能受到医院床位供应的限制.
研究的目的:
- 审查不同CSAI启动方法的证据.
- 为了比较CSAI的住院,门诊/日间病例和家庭启动方法.
- 评估各种CSAI启动策略的安全性,有效性和可访问性.
主要方法:
- 关于CSAI启动的已发表研究的文献综述.
- 分析有关住院,门诊/日间病例和家庭启动的数据.
- 在不同启动设置中比较并发症率和临床结果.
主要成果:
- 家庭启动CSAI是有效和安全的,与住院患者相比.
- 住院启动允许更快的定位,但面临着访问限制.
- 在家启动可以提供潜在的成本节约,并改善患者的访问.
结论:
- 灵活的CSAI启动方法,包括在家进行启动,可以改善帕金森病患者的治疗机会.
- 各种方法的并发症率是可比的,但患者特异性因素对选择至关重要.
- 优化CSAI启动策略对于管理高级PD电机波动至关重要.
相关概念视频
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Dosage Regimen: Individualization
167
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
167
One-Compartment Open Model for IV Bolus Administration: General Considerations
690
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
690
Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
224
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
224


